摘要
2020年10月17日,我国正式通过了《中华人民共和国生物安全法》,将生物安全列为国家安全的重要组成部分,明确了生物安全的重要地位。在新冠病毒感染疫情背景下,公共卫生领域发展广受重视。本文通过阐述生物安全与公共卫生的范畴,从新发突发传染病疫情、实验室生物安全和微生物耐药等方面,对当前我国公共卫生领域面临的生物安全风险进行综述,为促进我国公共卫生事业提供生物安全的参考视角。
On October 17,2020,China officially passed the Biosafety Law of the People's Republic of China,which lists biosecurity as an important part of national security and clarifies the important status of biosafety.The development of public health has received wide attention in the context of coronavirus disease 2019(COVID-19)pandemic.By expounding the scope of biosafety and public health,we review current biosafety risks in the field of public health in China from the aspects of emerging infectious disease outbreaks,laboratory biosafety and microbial resistance for providing a reference to relevant studies and practices.
作者
杨启凡
王宇萍
YANG Qifan;WANG Yuping(School of Population Medicine and Public Health,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100730,China)
出处
《中国公共卫生》
CAS
CSCD
北大核心
2023年第5期676-680,共5页
Chinese Journal of Public Health
基金
北京市教委支持国家“双一流”高校建设项目(2021-EFT-Z-009)。